Result Update. Sterling Tools. Buy

Similar documents
Result Update. Sterling Tools. Accumulate

Result Update. Atul Auto. Accumulate

Result Update. Ahluwalia Contracts. Buy

Result Update. Havells. Buy

MRF. Result Update. Accumulate

Result Update. Tech Mahindra. Buy

Result Update. Skipper. Sell

CONCOR. Management Meeting Update. Buy

Result Update. Khadim India. Buy

Infosys. Result Update. Buy

Bharat Petroleum Corporation

MRF. Result Update. Accumulate

Result Update. KEI Industries. Buy

Result Update ITC. Accumulate

Maruti Suzuki India. Result Update. Accumulate. Product mix driving margins

Techno Electric & Engineering

Result Update. NIIT Technologies. Buy

Voltas. Result Update. Buy. Q4FY18 Result (` Mn) May 21, 2018

Skipper. Result Update. Reduce

Maruti Suzuki India. Result Update. Accumulate. Growth Story Continues. Valuation (x) Estimates (` mn) Q3FY18 Result (` Mn)

Berger Paints. Result Update. Downgrade to Reduce (Prev. - Accumulate) Valuation (x) Estimates (` mn) Q2FY18 Result (` Mn) November 06, 2017

Transport Corporation of India

INOX Leisure. Result Update. Accumulate. Valuation (x) Estimates (` Mn) Q4FY18 Result (` Mn) May 08, 2018

GSK Pharma. Result Update. Buy

HCC. Result Update. Accumulate. Debt reduction factored in. Valuation (x) Estimates (` mn) Q2FY18 Result (` Mn) November 03, 2017

Larsen & Toubro. Result Update. Accumulate. Valuation (x) Estimates (` Bn) Q1FY18 Result (` Mn) July 26, 2018

Music Broadcast. Result Update. Buy. Valuation (x) Estimates (` Mn) Q1FY18 Result (` Mn)

Gujarat State Petronet

NCC. Result Update. Accumulate

Simplex Infrastructures

Balkrishna Industries

Shemaroo Entertainment

Skipper. Buy. Result Update. India (Capital Goods) Institutional Research DOLAT CAPITAL

Transport Corporation of India

Dilip Buildcon. Result Update. Buy. Stellar performance continues

Kajaria Ceramics. Result Update. Buy

Skipper. Accumulate. Result Update. India (Capital Goods) Institutional Research DOLAT CAPITAL

Q3FY19 Quarterly Preview IT Services

Result Update. HDFC Bank. Accumulate

Music Broadcast. Annual Report Analysis. Buy. Financials (` mn) August 31, 2018

Container Corporation of India

ICICI Bank. Result Update. Buy. Mixed bag. Valuation (x) Estimates (` mn) Q3FY18 Result (` Mn)

Mahanagar Gas. Result Update. Accumulate

Page Industries. Annual Report Analysis. Accumulate. FINANCIALS (` Mn) July 14, 2017

Dixon Technologies. Annual Report Analysis. Accumulate. Annual Report The IPO year. FINANCIALS (` Mn)

Particulars Q3FY15 Q3FY14 YoY (%) Q2FY15 QoQ (%) 9MFY15 9MFY14 YoY (%) Net Sales 3,774 3, , ,453 8,

Sagar Cement. Result Update. Buy. Valuation (x) Estimates (` mn) Q1FY19 Result (` Mn)

Kalpataru Power Transmission

Result Update. Yes Bank. Buy

Dilip Buildcon. Visit Note. Buy. FY18E a bumper year! Show continues!

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015

ICICI Bank. Result Update. Buy

JK Cement. Result Update. Buy. Q3FY18 Result (` Mn)

Repco Home Finance REPCO IN

Near-term pressure, but long-term outlook positive

BHEL SELL RESULTS REVIEW 1QFY15 13 AUG CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188

Visaka Industries Ltd

Fineotex Chemical Ltd

Still on track. Exhibit 1: ICT is on track for FY09E

Cummins India Ltd Bloomberg Code: KKC IN

Reliance Industries. Timing is everything BUY COMPANY UPDATE 1 OCT 2014

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

Jubilant FoodWorks NEUTRAL RESULTS REVIEW 4QFY17 30 MAY Highlights of the quarter

Symphony Ltd. RESULT UPDATE 31st October 2017

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

Hindustan Unilever (RHS)

Amber Enterprises India Ltd

Healty cigarette-driven growth

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

Ahluwalia Contracts (India)

Bayer Cropscience (BYRCS IN)

BLS International Services

Jubilant FoodWorks BUY RESULTS REVIEW 1QFY18 18 JULY Highlights of the quarter

MCX Ltd. Rating: Target price: EPS: Tepid volume growth continues. Target. Rating CMP. Rs. 1,080 SELL. Rs. 1,176

Vadodara II PPA yet to be signed; TP revised upward to Rs126 on FY19x

TTK Prestige Ltd. Result Highlights. Revenue growth of 41% YoY, shows no slowdown yet. OPM at ~15.8%; in line with our estimate

Simplex Infrastructures

TVS Motors. Source: Company Data; PL Research

Religare Investment Call

Crompton Greaves Consumer Electricals

BHEL.BO BHEL IN. Structural story remains weak. Q1FY19 Result Update. Rating: REDUCE CMP: Rs72 TP: Rs73. July 25, 2018

Crompton Greaves Consumer Electricals

JK Lakshmi Cement. Source: Company Data; PL Research

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

Maruti Suzuki. Source: Company Data; PL Research

Britannia Industries

Maruti Suzuki. Source: Company Data; PL Research

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Religare Investment Call

Transport Corporation of India Ltd.

Coal India. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Asian Paints. Source: Company Data; PL Research

KEC International. Annual Report Analysis. Accumulate

Mphasis. Increased confidence on margins. Source: Company Data; PL Research

Bharat Forge. Exports remain subdued, outlook better. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Mahindra & Mahindra. Source: Company Data; PL Research

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS.

J. Kumar Infraprojects

Transcription:

Sterling Tools Buy Result Update Growth momentum continues Sterling tools (STRT) number were broadly in line with estimates. Margins on a sequential basis have started showing signs of improvement at gross level. Considering that raw material pressure has been easing, we expect margins to remain stable / expand from current levels. This will b driven by increase in proportion of specialized fasteners. With capacity expansion on schedule, we believe that STRT will continue to grow on revenue front with strong margins. Effort to expand customer base will also augur well in long term. Considering the market outlook and increase in risk free rate, we have adjusted PER accordingly. We continue to like the story on a structural basis and reiterate BUY with a target price of ` 413. Growing faster than Automobile Industry STRT has outperformed the overall automobile industry growth on the top line growth front and the same is expected to continue. We expect the Indian automobile industry to grow at 8-10% and expect the STRT to grow ahead at 10-12% on the back of increasing content per vehicle and higher demand on premium products. Due to the consumer shift on premium automobile products, the penetration of specialized fasteners is expected to improve, giving better realizations on favorable product mix and higher margins. Softening raw material prices RM prices have been easing in the last couple of months. The margins are also expected to improve due to increasing specialized fasters and economies of scale. We expect STRT to show better margins for the overall year FY19. Valuation With the new addition of the products, new greenfield plant coming up by Q1FY20, faster than industry growth rate and expected margin improvement along with strong return ratios, we believe that STRT is a compelling story. We reiterate BUY with a target price of 413. Q2FY19 Result (` Mn) Particulars Q2FY19 Q2FY18 YoY (%) Q1FY19 QoQ (%) Revenue 1,393 1,158 20.3 1,313 6.2 Total Expense 1,126 889 26.7 1,060 6.2 EBITDA 267 269 (0.7) 252 5.9 Depreciation 46 43 6.2 46 1.3 EBIT 221 226 (2.0) 207 6.9 Other Income 17 14 17.2 19 (9.8) Interest 7 9 (25.6) 7 (5.7) EBT 231 231 (2.0) 218 5.9 Tax 79 84 (5.8) 78 1.3 RPAT 152 147 3.5 140 8.4 APAT 152 147 3.5 140 8.4 (bps) (bps) Gross Margin (%) 59.4 64.4 (493) 59.0 42 EBITDA Margin (%) 19.2 23.2 (406) 19.2 (5) NPM (%) 10.9 12.7 (178) 10.7 23 Tax Rate (%) 34.1 36.3 (215) 35.7 (154) EBIT Margin (%) 15.9 19.5 (362) 15.8 11 CMP `350 Target / Upside `413 / 18% BSE Sensex 35,457 NSE Nifty 10,682 Scrip Details Equity / FV `72mn / ` 2 Market Cap `13bn US$ 176mn 52-week High/Low ` 478/` 307 Avg. Volume (no) 11,843 NSE Symbol Bloomberg Code STERTOOLS Shareholding Pattern Sep'18(%) STRT IN Promoters 65.3 MF/Banks/FIs 6.7 FIIs 0.0 Public / Others 28.0 Valuation (x) FY18A FY19E FY20E P/E 25.9 21.1 17.0 EV/EBITDA 13.8 11.2 9.1 ROE (%) 24.2 23.6 25.7 RoACE (%) 19.1 20.8 23.4 Estimates (` mn) FY18A FY19E FY20E Revenue 4,529 5,374 6,156 EBITDA 907 1,114 1,349 PAT 487 597 741 EPS (Rs.) 13.5 16.6 20.6 VP Research: Priyank Chandra Tel: +91 22 40969737 E-mail: priyank@dolatcapital.com Associate: Kushal Shah Tel: +91 22 40969768 E-mail: kushals@dolatcapital.com November 17, 2018

Annual Charts Revenue (` Mn) Revenue Growth (%) 7,000 6,156 25 22.1 6,000 5,374 18.7 20 5,000 4,529 14.6 4,000 3,694 3,709 3,401 15 12.8 3,014 3,000 8.6 10 6.7 2,000 1,000 5 0.4 0 0 Gross Profit (` Mn) Gross Margin (%) 5,000 65 4,000 3,000 2,000 1,710 1,928 2,259 2,369 2,847 3,424 3,944 63 61 59 61.2 63.9 62.9 63.7 64.1 1,000 57 0 55 56.7 56.7 65 63 61 59 57 55 Operating Profit (` Mn) Operating Margin (%) 24 21.9 63.9 63.7 64.1 22 20.4 20.0 20.7 62.9 20 61.2 18 16.8 16 13.9 14 13.7 56.7 56.7 12 November 17, 2018 2

Net Profit (` Mn) Net Margin (%) 800 741 13 12.0 700 12 597 11.1 10.6 10.7 600 11 487 500 10 393 400 9 284 7.7 300 213 8 200 158 7 6.3 100 6 5.3 0 5 29 27 25 23 21 19 17 15 ROE (%) ROCE (%) 26.4 27.3 40 36.7 25.7 35 33.0 32.7 22.7 23.6 30 27.0 19.6 25 23.1 16.7 20 17.1 18.1 15 Quarterly Charts Gross Margin (%) Operating Margin (%) 70 65 60 55 59.4 56.5 60.6 54.6 61.9 60.5 65.3 66.2 63.5 61.4 61.6 64.4 61.1 65.6 60.8 59.0 59.4 70 65 60 55 59.4 56.5 60.6 54.6 61.9 60.5 65.3 66.2 63.5 61.4 61.6 64.4 61.1 65.6 60.8 59.0 59.4 50 50 Q1FY15 Q2FY15 Q3FY15 Q4FY15 Q1FY16 Q2FY16 Q3FY16 Q4FY16 Q1FY17 Q2FY17 Q3FY17 Q4FY17 Q1FY18 Q2FY18 Q3FY18 Q4FY18 Q1FY19 Q2FY19 Q1FY15 Q2FY15 Q3FY15 Q4FY15 Q1FY16 Q2FY16 Q3FY16 Q4FY16 Q1FY17 Q2FY17 Q3FY17 Q4FY17 Q1FY18 Q2FY18 Q3FY18 Q4FY18 Q1FY19 Q2FY19 November 17, 2018 3

Profit and Loss Account (` Mn) FY17A FY18A FY19E FY20E Revenue 3,709 4,529 5,374 6,156 Total Expense 2,952 3,622 4,260 4,807 COGS 1,340 1,683 1,951 2,213 Employees Cost 308 335 386 443 Other expenses 1,304 1,605 1,924 2,151 EBIDTA 757 907 1,114 1,349 Depreciation 166 176 190 209 EBIT 590 731 924 1,141 Interest 56 38 25 20 Other Income 69 56 20 20 Exc. / E.O. items 0 0 0 0 EBT 604 749 919 1,140 Tax 212 263 322 399 RPAT 392 487 597 741 Minority Interest 0 0 0 0 Profit/Loss share of associates 0 0 0 0 APAT 392 487 597 741 Balance Sheet (` Mn) FY17A FY18A FY19E FY20E Sources of Funds Equity Capital 68 72 72 72 Minority Interest 0 0 0 0 Reserves & Surplus 1,571 2,308 2,611 3,016 Net Worth 1,640 2,380 2,683 3,088 Total Debt 402 302 252 202 Net Deferred Tax Liability 156 100 50 50 Total Capital Employed 2,198 2,783 2,985 3,340 Applications of Funds Net Block 1,431 1,535 1,645 1,736 CWIP 0 21 23 25 Investments 179 179 179 179 Current Assets, Loans & Advances 981 1,431 1,559 1,854 Inventories 459 521 589 641 Receivables 342 409 442 506 Cash and Bank Balances 28 356 389 575 Loans and Advances 142 135 128 122 Other Current Assets 9 10 10 10 Less: Current Liabilities & Provisions 394 384 420 454 Payables 286 365 442 523 Other Current Liabilities 108 19 (22) (69) sub total Net Current Assets 588 1,048 1,139 1,400 Total Assets 2,198 2,783 2,985 3,340 E Estimates November 17, 2018 4

Important Ratios Particulars FY17A FY18A FY19E FY20E (A) Margins (%) Gross Profit Margin 63.9 62.9 63.7 64.1 EBIDTA Margin 20.4 20.0 20.7 21.9 EBIT Margin 15.9 16.1 17.2 18.5 Tax rate 35.1 35.1 35.0 35.0 Net Profit Margin 10.6 10.7 11.1 12.0 (B) As Percentage of Net Sales (%) COGS 36.1 37.1 36.3 35.9 Employee 8.3 7.4 7.2 7.2 Other 35.2 35.4 35.8 34.9 (C) Measure of Financial Status Gross Debt / Equity 0.2 0.1 0.1 0.1 Interest Coverage 10.6 19.3 36.6 56.4 Inventory days 45 42 40 38 Debtors days 34 33 30 30 Average Cost of Debt 10.2 10.7 9.1 8.9 Payable days 28 29 30 31 Working Capital days 58 84 77 83 FA T/O 2.6 2.9 3.3 3.5 (D) Measures of Investment AEPS (`) 10.9 13.5 16.6 20.6 CEPS (`) 15.5 18.4 21.9 26.4 DPS (`) 2.0 4.0 7.0 8.0 Dividend Payout (%) 17.5 29.5 42.1 38.8 BVPS (`) 45.5 66.1 74.5 85.7 RoANW (%) 26.4 24.2 23.6 25.7 RoACE (%) 17.6 19.1 20.8 23.4 RoAIC (%) 27.9 31.8 36.8 42.6 (E) Valuation Ratios CMP (`) 350 350 350 350 P/E 32.2 25.9 21.1 17.0 Mcap (` Mn) 12,610 12,610 12,610 12,610 MCap/ Sales 3.4 2.8 2.3 2.0 EV 12,984 12,557 12,473 12,237 EV/Sales 3.5 2.8 2.3 2.0 EV/EBITDA 17.2 13.8 11.2 9.1 P/BV 7.7 5.3 4.7 4.1 Dividend Yield (%) 0.5 1.1 2.0 2.3 (F) Growth Rate (%) Revenue 0.4 22.1 18.7 14.6 EBITDA 22.3 19.8 22.9 21.1 EBIT 21.8 23.8 26.4 23.4 PBT 38.9 24.1 22.6 24.1 APAT 36.1 24.1 22.7 24.1 EPS 36.1 24.1 22.7 24.1 Cash Flow (` Mn) FY17A FY18A FY19E FY20E CFO 590 525 706 895 CFI (249) (313) (302) (302) CFF (422) 116 (369) (407) FCFF 456 204 403 592 Opening Cash 115 28 356 389 Closing Cash 28 356 389 575 E Estimates November 17, 2018 5

May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 Nov-18 DART RATING MATRIX Total Return Expectation (12 Months) Buy > 20% Accumulate 10 to 20% Reduce 0 to 10% Sell < 0% Rating and Target Price History 510 450 (Rs) STRT Target Price Month Rating TP (Rs.) Price (Rs.) Nov-17 Buy 364 299 Feb-18 Accumulate 477 399 May-18 Buy 475 389 390 330 270 210 * Price as on recommendation date DART Team Purvag Shah Managing Director purvag@dolatcapital.com +9122 4096 9747 Amit Khurana, CFA Head of Equities amit@dolatcapital.com +9122 4096 9745 CONTACT DETAILS Equity Sales Designation E-mail Direct Lines Dinesh Bajaj VP - Equity Sales dineshb@dolatcapital.com +9122 4096 9709 Kartik Sadagopan VP - Equity Sales kartiks@dolatcapital.com +9122 4096 9762 Kapil Yadav VP - Equity Sales kapil@dolatcapital.com +9122 4096 9735 Equity Trading Designation E-mail P. Sridhar SVP and Head of Sales Trading sridhar@dolatcapital.com +9122 4096 9728 Chandrakant Ware VP - Sales Trading chandrakant@dolatcapital.com +9122 4096 9707 Shirish Thakkar VP - Head Domestic Derivatives Sales Trading shirisht@dolatcapital.com +9122 4096 9702 Kartik Mehta VP - Head Asia Derivatives Sales Trading kartikm@dolatcapital.com +9122 4096 9715 Bhavin Mehta VP - Derivatives Strategist bhavinm@dolatcapital.com +9122 4096 9705 Dolat Capital Market Private Limited. Sunshine Tower, 28th Floor, Senapati Bapat Marg, Dadar (West), Mumbai 400013

Analyst(s) Certification The research analyst(s), with respect to each issuer and its securities covered by them in this research report, certify that: All of the views expressed in this research report accurately reflect his or her or their personal views about all of the issuers and their securities; and No part of his or her or their compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in this research report. I. Analyst(s) and Associate (S) holding in the Stock(s): (Nil) II. Disclaimer: This research report has been prepared by Dolat Capital Market Private Limited. to provide information about the company(ies) and sector(s), if any, covered in the report and may be distributed by it and/or its affiliated company(ies) solely for the purpose of information of the select recipient of this report. This report and/or any part thereof, may not be duplicated in any form and/or reproduced or redistributed without the prior written consent of Dolat Capital Market Private Limited. This report has been prepared independent of the companies covered herein. Dolat Capital Market Private Limited. and its affiliated companies are part of a multi-service, integrated investment banking, brokerage and financing group. Dolat Capital Market Private Limited. and/or its affiliated company(ies) might have provided or may provide services in respect of managing offerings of securities, corporate finance, investment banking, mergers & acquisitions, financing or any other advisory services to the company(ies) covered herein. Dolat Capital Market Private Limited. and/or its affiliated company(ies) might have received or may receive compensation from the company(ies) mentioned in this report for rendering any of the above services. Research analysts and sales persons of Dolat Capital Market Private Limited. may provide important inputs to its affiliated company(ies) associated with it. While reasonable care has been taken in the preparation of this report, it does not purport to be a complete description of the securities, markets or developments referred to herein, and Dolat Capital Market Private Limited. does not warrant its accuracy or completeness. Dolat Capital Market Private Limited. may not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. This report is provided for information only and is not an investment advice and must not alone be taken as the basis for an investment decision. The investment discussed or views expressed herein may not be suitable for all investors. The user assumes the entire risk of any use made of this information. The information contained herein may be changed without notice and Dolat Capital Market Private Limited. reserves the right to make modifications and alterations to this statement as they may deem fit from time to time. Dolat Capital Market Private Limited. and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. This report is neither an offer nor solicitation of an offer to buy and/or sell any securities mentioned herein and/or not an official confirmation of any transaction. This report is not directed or intended for distribution to, or use by any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject Dolat Capital Market Private Limited. and/or its affiliated company(ies) to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to a certain category of investors. Persons in whose possession this report may come, are required to inform themselves of and to observe such restrictions. For U.S. Entity/ persons only: This research report is a product of Dolat Capital Market Private Limited., which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States (U.S.) and are not associated persons of any U.S. regulated broker-dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker-dealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public appearances and trading securities held by a research analyst account. This report is intended for distribution by Dolat Capital Market Private Limited. only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any U.S. person or entity. In reliance on the exemption from registration provided by Rule 15a-6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major Institutional Investors, Dolat Capital Market Private Limited. has entered into an agreement with a U.S. registered brokerdealer Ltd Marco Polo Securities Inc. ("Marco Polo"). Transactions in securities discussed in this research report should be effected through Marco Polo or another U.S. registered broker dealer/entity as informed by Dolat Capital Market Private Limited. from time to time. Dolat Capital Market Private Limited. Corporate Identity Number: U65990DD1993PTC009797 Member: BSE Limited and National Stock Exchange of India Limited. SEBI Registration No: BSE - INB010710052 & INF010710052, NSE - INB230710031& INF230710031, Research: INH000000685 Registered office: Office No. 141, Centre Point, Somnath, Daman 396 210, Daman & Diu Board: +9122 40969700 Fax: +9122 22651278 Email: research@dolatcapital.com www.dolatcapital.com Our Research reports are also available on Reuters, Thomson Publishers, DowJones and Bloomberg (DCML <GO>)

Our Research reports are also available on Reuters, Thomson Publishers, DowJones and Bloomberg (DCML <GO>)